Testosterone Therapy in Hypogonadism Can Prevent Progression to T2DM
Men with prediabetes, hypogonadism achieved normal glucose regulation with TTh
Hypogonadism
HYPOGONADISM
Testosterone Use Remains High Among Men With Coronary Artery Disease
Despite research suggesting that there may be increased cardiovascular risk from off-label prescription testosterone use, usage in men with coronary artery disease remains higher than in men without coronary artery disease.
Medical Marketing Has Increased in Past 20 Years
Considerable increase seen from 1997 through 2016, especially in direct-to-consumer advertising
Hypogonadism Predicts Varicocele Repair
Hypogonadism and serum testosterone evaluation nearly doubled the odds a man would undergo varicocelectomy.
Testosterone Measurements, TRT Prescribing Infrequent in PCa Care
More than half of UK specialists surveyed said measuring testosterone levels in patients with nonmetastatic prostate cancer was not their routine practice.
Study: Testosterone Replacement Does Not Increase DVT Risk
In a study, the rate of deep vein thrombosis in treated hypogonadal men was just 0.8% over 2 years of follow-up.
Xyosted Now Available for Treatment of Testosterone Deficiency
Prior to starting Xyosted, the patient’s baseline cardiovascular risk should be considered and blood pressure should be adequately controlled.
Testosterone Therapy May Ease Depressive Symptoms
Meta-analysis suggests that testosterone treatment enhances mood in hypogonadal and eugonadal men.
Study: TRT May Improve Mobility, But Not Fall Risk
In a study, older men with difficulty walking or climbing stairs reported better physical function after testosterone therapy.
Auto-Injected Testosterone May Address Some TRT Shortcomings
Single-dose disposable auto injector approved for once-weekly subcutaneous administration of testosterone may cut down on potential problems associated with other options.
Want to read more?
Please login or register first to view this content.
Next post in Hypogonadism
